Targeting the function of IFN-γ-inducible protein 10 suppresses ongoing adjuvant arthritis

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2685-2693

  Salomon, Izhar ^a   Netzer, Nir ^a   Wildbaum, Gizi ^a   Schif Zuck, Sagie ^a   Maor, Gila ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTIBODY; CHEMOKINE RECEPTOR CXCR3; DNA VACCINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON INDUCIBLE PROTEIN 10 ANTIBODY; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; GENETIC CODE; IMMUNE SYSTEM; IMMUNITY; LEUKOCYTE MIGRATION; LYMPHOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0036721708     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2685     Document Type: Article

References (53)

1. Rheumatoid arthritis: Pathophysiology and implications for therapy
2. Development of arthritis, periarthritis and periostitis in rats given adjuvants
3. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids
4. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
5. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
6. Anti-tumor necrosis factor-α therapy of rheumatoid arthritis
7. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis
8. Biologic agents for treating rheumatoid arthritis: Concepts and progress
9. Role of cytokines in rheumatoid arthritis
10. Chemokines and their receptors in infectious disease
11. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
12. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL/lpr mouse model
13. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model
14. + T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis
15. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
16. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
17. A Toll-like receptor recognizes bacterial DNA
18. DNA-PKCs is required for activation of innate immunity by immunostimulatory DNA
19. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-α) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis
20. A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis
21. A targeted DNA vaccine augments the natural immune response to self TNF-α and suppresses adjuvant arthritis
22. Long-lasting, protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines
23. Prevention of experimental autoimmune encephalomyelitis by MIP-1α and MCP-1 naked DNA vaccines
24. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis
25. Interferon-inducible T cell α chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
26. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
27. + T cells
28. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice
29. + T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
30. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes
31. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
32. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
33. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163)
34. Myelin-liposome protection against experimental autoimmune encephalomyelitis is associated with reduced neuroantigen-specific T-cell-mediated responses
35. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
36. Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis
37. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery
38. Systemic immunological effects of cytokine genes injected into skeletal muscle
39. Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model
40. Production of monoclonal antibodies by genetic immunization
41. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T cell costimulation
42. DNA vaccines: Immunology, applications and optimization
43. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis
44. The role of chemokines in inflammatory joint disease
45. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice
46. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease
47. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls
48. Cytokines in rheumatoid arthritis: New therapeutic possibilities
49. CC chemokine receptor 5 polymorphism in rheumatoid arthritis
50. Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis
51. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway
52. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs
53. Plasmid DNA encoding IFN-γ-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis